Cases 21 - 30 of 61
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Biocon Pharma Ltd. et al
as 1:2022cv00937
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Biocon Pharma Ltd., Biocon Ltd. and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Biocon Pharma Ltd. et al
as 1:2022cv00936
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Biocon Pharma Ltd., Biocon Ltd. and Biocon Pharma, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries, Inc., et al
as 1:2022cv00897
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv00896
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Orbicular Pharmaceutical Technologies Pvt. Ltd.
as 1:2022cv00856
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Orbicular Pharmaceutical Technologies Pvt. Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk, Inc. et al v. Mylan Pharmaceuticals, Inc.
as 1:2022cv00023
Counter Defendant:
Novo Nordisk, Inc. and Novo Nordisk, A/S
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk A/S et al v. Sun Pharmaceutical Industries Ltd. et al
as 1:2022cv00296
Plaintiff:
Novo Nordisk A/S and Novo Nordisk Inc.
Defendant:
Sun Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Aurobindo Pharma USA, Inc. et al
as 1:2022cv00295
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Aurobindo Pharma USA, Inc., Aurobindo Pharma Ltd. and Eugia Pharma Specialties Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Rio Biopharmaceuticals, Inc. et al
as 1:2022cv00294
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Rio Biopharmaceuticals, Inc. and EMS S/A
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
